Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 16, 2022; 10(29): 10451-10466
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10451
Table 3 Analysis of survival and prognosis of patients with early gastric cancer
Variable
OS (EGC = 1305) or (95%CI)
P value
OS (SRC = 313) or (95%CI)
P value
Age (yr)< 0.0010.128
< 401 (Reference)1 (Reference)
40-601.189 (0.282-5.015)0.8131.071 (0.128-8.947)0.950
60-802.246 (0.550-9.174)0.2602.072 (0.268-16.012)0.485
> 805.516 (1.337-22.753)0.0184.204 (0.463-38.177)0.202
Race< 0.0010.093
White1 (Reference)1 (Reference)
Black1.459 (1.053-2.022)0.0232.052 (0.878-4.793)0.097
Black-AI1.947 (0.476-7.960)0.3540.0000.990
Black-API0.497 (0.358-0.691)< 0.0010.471 (0.137-1.271)0.124
Sex
Male1 (Reference)1 (Reference)
Female0.610 (0.467-0.797)< 0.0010.791 (0.383-1.632)0.526
Tumor size (cm)0.0570.700
< 21 (Reference)1 (Reference)
2-51.317 (0.982-1.764)0.0661.579 (0.707-3.525)0.265
> 51.859 (1.161-2.978)0.0100.0000.974
AJCC stage
I1 (Reference)1 (Reference)
II1.836 (1.100-3.064)0.0200.965 (0.231-4.027)0.961
Depth
T1a1 (Reference)1 (Reference)
T1b1.280 (0.962-1.703)0.0901.786 (0.810-3.938)0.151
LNM1
N01 (Reference)1 (Reference)
N1-31.271 (0.859-1.880)0.2302.134 (0.883-5.154)0.151
Histology0.045
Differentiated 1(Reference)
SRC0.636 (0.426-0.950)0.027
Undifferentiated1.039 (0.780-1.384)0.794
SRC vs non-SRC0.626 (0.427-0.919)0.017